A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.
מצבים רפואיים
Solid Tumours · Advanced Solid Tumours
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Gosford Hospital, Gosford, New South Wales, Australia
Contact: Principal Investigator (Dr. Craig Kukard)Cancer Care Foundation, Miranda, New South Wales, Australia
Contact: Principal Investigator (Dr Mahmood Alam)Wyong Hospital, Wyong, New South Wales, Australia
Contact: Principal Investigator (Dr. Craig Kukard)Queen Mary Hospital, Hong Kong, Hong Kong
Contact: Principal Investigator (Dr. Roland Ching Yu Leung)Prince of Wales Hospital, Shatin, Hong Kong
Contact: Principal Investigator (Dr. Herbert Loong)Asan Medical Centre, Seoul, South Korea
Contact: Principal Investigator (Prof. JeongEun Kim)Ewha Womans University MokDong Hospital, Seoul, South Korea
Contact: Principal Investigator (Prof. JungMin Jo)Samsung Medical Centre, Seoul, South Korea
Contact: Principal Investigator (Prof JungYong Hong)Severance Hospital, Yonsei University, Health System, Seoul, South Korea
Contact: Principal Investigator (HyoSong Kim)
מובילי המחקר
Marinella Messina
Study Director
Racura Oncology Ltd